# BigHat Biosciences raises USD 75 million in Series C funding

On 2026/9/24, Presspool reported that BigHat Biosciences, a US AI antibody design company, raised USD 75 million in Series C funding, led by DFJ Growth and Premji Invest.



Canonical: https://uniquebase.ai/news/3ecc35f9-2d7e-4956-a515-77cfdf0f0316
Stable identifier: 3ecc35f9-2d7e-4956-a515-77cfdf0f0316
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:31:08.171Z

## Connected profiles

- [BigHat Biosciences](/companies/bighat-biosciences)
- [DFJ Growth](/institutions/dfj-growth)
- [Premji Invest](/institutions/premji-invest)

## Sources

- https://presspool.ai/ai-startup-funding/week-of-2026-09-21